Kenya

in page functions
[French]
Kenya
Total population (2018) 49,695,147
Birth cohort (2018) 1,616,334
Surviving Infants (surviving to 1 year per year, 2018) 1,539,406
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 36/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 49/1000
World Bank Index, IDA (2015) 3.82
Gross Nation Income (per capita US$, 2015) 1,340
No. of districts/territories (2017) 47

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Kenya

Type of support

Approvals

2001-2023 (US$)
(2 Jul 2019)

Commitments

2001-2023 (US$)
(2 Jul 2019)

Disbursements

2000-2019 (US$)
(2 Jul 2019)

% Disbursed

(2 Jul 2019)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $499,320,934 $504,820,704 $503,506,062
Cash Support (CASHSUPP) $348,000 $348,000 $145,000 42%
Cold Chain Equipment Optimisation Platform (CCEOP) $6,080,189 $6,080,189 $2,295,631 38%
Health system strengthening (HSS 1) $8,079,544 $8,079,544 $8,079,544 100%
Health system strengthening (HSS 2) $14,840,190 $20,339,960 $9,023,087 61%
HPV (NVS) $6,674,000 $6,674,000 $5,981,400 90%
HPV Demo (NVS) $398,838 $398,838 $265,338 67%
Immunisation services support (ISS) $6,384,766 $6,384,766 $6,384,766 100%
Injection Safety Devices (NVS) $1,543,000 $1,543,000 $1,858,993 120%
Injection safety support (INS) $1,129,963 $1,129,963 $1,129,963 100%
IPV (NVS) $7,528,665 $7,528,665 $5,925,865 79%
Measles-Rubella (NVS) $13,513,824 $13,513,824 $13,513,824 100%
Meningitis A - campaign (NVS) $2,409,964 $2,409,964 $2,409,964 100%
Meningitis A - operational costs (OPC) $1,714,144 $1,714,144 $1,714,140 100%
MR - Operational costs (OPC) $12,332,500 $12,332,500 $12,332,500 100%
MR-Follow-up campaign (NVS) $4,979,500 $4,979,500 $5,138,960 103%
MR-Follow-up campaign op.costs (OPC) $3,989,174 $3,989,174 $3,989,174 100%
Penta (NVS) $171,194,211 $171,194,211 $171,328,494 100%
Pneumo (NVS) $197,834,472 $197,834,472 $214,687,036 109%
Product Switch Grant (PSG) $379,460 $379,460 $370,531 98%
Rotavirus (NVS) $30,989,921 $30,989,921 $29,860,395 96%
Vaccine Introduction Grant (VIG) $6,229,235 $6,229,235 $6,229,228 100%
Yellow Fever (NVS) $747,374 $747,374 $842,229 113%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Kenya DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 71%
M:F sex ratio at birth (2018) 1.03
Household survey: DTP3 coverage for male (2013) 89.60%
Household survey: DTP3 coverage for female (2013) 90.20%
Household survey: Last DTP3 survey (2013) 90%
% districts achieving > 80% DTP3 coverage (2017) 32%
% districts achieving < 50% DTP3 coverage (2017) 4%
MCV WHO/UNICEF estimates (2017) 89%

Breakdown of support

Non-vaccine support Vaccine support
10% 90%
$51,693,564 $451,812,498

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Kenya

23 April 2019

Gavi item

Partnership welcomes launch of first malaria vaccine pilot

Funding agencies hail important step for the world’s first malaria vaccine.

27 March 2019

Gavi item

Leadership training for supply chain managers expands to five African countries

Over 22 private sector partners will support the innovative training and mentorship programme.

14 March 2019

The Vaccine Goal

Pneumococcal vaccine price drops for third year running

In agreement with Gavi, Pfizer reduces price of pneumococcal vaccine to US$ 2.90 per dose for Gavi-eligible countries.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here